Acumen Pharmaceuticals, Inc. Stock Forecast
Is Acumen Pharmaceuticals, Inc. stock still a buy after falling -5.30% on Monday?
(Updated on Jun 17, 2024)
The Acumen Pharmaceuticals, Inc. stock price fell by -5.30% on the last day (Monday, 17th Jun 2024) from $2.64 to $2.50. During the last trading day the stock fluctuated 6.85% from a day low at $2.48 to a day high of $2.65. The price has fallen in 5 of the last 10 days and is down by -9.09% for this period. Volume has increased on the last day by 71 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 276 thousand shares were bought and sold for approximately $690.54 thousand.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.34 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -28.44% during the next 3 months and, with a 90% probability hold a price between $1.67 and $2.45 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ABOS Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, June 06, 2024, and so far it has risen 0.402%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Acumen Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.62 and $3.18. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Acumen Pharmaceuticals, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Acumen Pharmaceuticals, Inc. stock
Acumen Pharmaceuticals, Inc. finds support from accumulated volume at $2.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.170 between high and low, or 6.85%. For the last week, the stock has had daily average volatility of 5.50%.
Acumen Pharmaceuticals, Inc. is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ABOS) For The Upcoming Trading Day Of Tuesday 18th
For the upcoming trading day on Tuesday, 18th we expect Acumen Pharmaceuticals, Inc. to open at $2.54, and during the day (based on 14 day Average True Range), to move between $2.31 and $2.69, which gives a possible trading interval of +/-$0.191 (+/-7.64%) up or down from last closing price. If Acumen Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 15.27% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.49 (0.40%) than the resistance at $2.58 (3.20%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Acumen Pharmaceuticals, Inc. stock A Buy?
Acumen Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -4.696 Sell Candidate Unchanged
Predicted Opening Price for Acumen Pharmaceuticals, Inc. of Tuesday, June 18, 2024
| Fair opening price June 18, 2024 | Current price |
|---|---|
| $2.54 ( 1.73%) | $2.50 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ABOS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.71 | 8.53% |
| R2 | 2.65 | 5.94% |
| R1 | 2.61 | 4.33% |
| Price | 2.50 | |
| S1 | 2.48 | -0.86% |
| S2 | 2.44 | -2.47% |
| S3 | 2.37 | -5.07% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.64 | 5.60% |
| R2 | 2.62 | 4.80% |
| R1 | 2.58 | 3.20% |
| Price | 2.50 | |
| S1 | 2.49 | -0.400% |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Acumen Pharmaceuticals, Inc. Stock.
